Alpha1-Proteinase Inhibitor (Human) 15%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alpha1-Proteinase Inhibitor (Human) 15%, covering 2025-12-12 to 2025-12-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency [Phase 1, Phase 2]